Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry O Fischmann

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 1Michael P Dwyer, Kamil Paruch, Marc Labroli, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitorsXiaohua Huang, Cliff C Cheng, Thierry O Fischmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2007
Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitorsMichael P Dwyer, Kamil Paruch, Carmen Alvarez, et al.
Biopolymers|October 17, 2007
Structure-guided discovery of cyclin-dependent kinase inhibitorsThierry O Fischmann, Alan Hruza, José S Duca, et al.
Communications Biology|June 19, 2023
Conserved allosteric inhibitory site on the respiratory syncytial virus and human metapneumovirus RNA-dependent RNA polymerasesVictoria A Kleiner, Thierry O Fischmann, John A Howe, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of InflammationWilliam T McElroy, Zheng Tan, Ginny Ho, et al.
Communications Biology|July 31, 2023
Structural insights into selective small molecule activation of PKG1αEssam Metwally, Victor Mak, Aileen Soriano, et al.
ACS Chemical Biology|February 8, 2018
Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass SpectrometryNoreen F Rizvi, John A Howe, Ali Nahvi, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapyThierry O Fischmann, Daniel Malashock, Eunseon Ahn, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 1Michael P Dwyer, Kamil Paruch, Marc Labroli, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitorsXiaohua Huang, Cliff C Cheng, Thierry O Fischmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2007
Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitorsMichael P Dwyer, Kamil Paruch, Carmen Alvarez, et al.
Biopolymers|October 17, 2007
Structure-guided discovery of cyclin-dependent kinase inhibitorsThierry O Fischmann, Alan Hruza, José S Duca, et al.
Communications Biology|June 19, 2023
Conserved allosteric inhibitory site on the respiratory syncytial virus and human metapneumovirus RNA-dependent RNA polymerasesVictoria A Kleiner, Thierry O Fischmann, John A Howe, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of InflammationWilliam T McElroy, Zheng Tan, Ginny Ho, et al.
Communications Biology|July 31, 2023
Structural insights into selective small molecule activation of PKG1αEssam Metwally, Victor Mak, Aileen Soriano, et al.
ACS Chemical Biology|February 8, 2018
Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass SpectrometryNoreen F Rizvi, John A Howe, Ali Nahvi, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapyThierry O Fischmann, Daniel Malashock, Eunseon Ahn, et al.
Pageof 3